• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病在急性心肌梗死后时间进程中的预后影响差异。

Differential prognostic impacts of diabetes over time course after acute myocardial infarction.

机构信息

Department of Internal Medicine, Cardiovascular Center, Seoul National University Boramae Medical Center, Seoul, Korea.

出版信息

J Korean Med Sci. 2013 Dec;28(12):1749-55. doi: 10.3346/jkms.2013.28.12.1749. Epub 2013 Nov 26.

DOI:10.3346/jkms.2013.28.12.1749
PMID:24339704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3857370/
Abstract

This study was performed to evaluate the effects of diabetes on short- and mid-term clinical outcomes in patients with acute myocardial infarction (AMI). Between October 2005 and December 2009, a total of 22,347 patients with AMI from a nationwide registry was analyzed. At the time point of the day 30 after AMI onset, landmark analyses were performed for the development of major adverse cardiovascular events (MACEs), including death, re-infarction and revascularization. In this cohort, 6,131 patients (27.4%) had diabetes. Short-term MACEs, which occurred within 30 days of AMI onset, were observed in 1,364 patients (6.1%). Among the 30-day survivors (n = 21,604), mid-term MACEs, which occurred between 31 and 365 days after AMI onset, were observed in 1,181 patients (5.4%). After adjustment for potential confounders, diabetes was an independent predictor of mid-term MACEs (HR, 1.25; 95% CI, 1.08-1.45; P = 0.002), but not of short-term MACEs (HR: 1.16; 95% CI: 0.93-1.44; P = 0.167). Diabetes is a poor prognostic factor for mid-term clinical outcomes but not for short-term outcomes in AMI patients. Careful monitoring and intensive care should be considered in diabetic patients, especially following the acute stage of AMI.

摘要

本研究旨在评估糖尿病对急性心肌梗死(AMI)患者短期和中期临床结局的影响。在 2005 年 10 月至 2009 年 12 月期间,对来自全国注册登记处的 22347 例 AMI 患者进行了分析。在 AMI 发病后 30 天的时间点,对主要不良心血管事件(MACE)的发生进行了里程碑式分析,包括死亡、再梗死和血运重建。在该队列中,6131 例患者(27.4%)患有糖尿病。短期 MACE 发生在 AMI 发病后 30 天内,共 1364 例(6.1%)。在 30 天存活者(n=21604)中,中期 MACE 发生在 AMI 发病后 31 至 365 天之间,共 1181 例(5.4%)。在校正潜在混杂因素后,糖尿病是中期 MACE 的独立预测因素(HR,1.25;95%CI,1.08-1.45;P=0.002),但不是短期 MACE 的独立预测因素(HR:1.16;95%CI:0.93-1.44;P=0.167)。糖尿病是 AMI 患者中期临床结局的不良预后因素,但不是短期结局的不良预后因素。应考虑在糖尿病患者中进行仔细监测和强化护理,特别是在 AMI 的急性阶段之后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb8d/3857370/66869bc679f6/jkms-28-1749-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb8d/3857370/8851836161f1/jkms-28-1749-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb8d/3857370/66869bc679f6/jkms-28-1749-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb8d/3857370/8851836161f1/jkms-28-1749-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb8d/3857370/66869bc679f6/jkms-28-1749-g002.jpg

相似文献

1
Differential prognostic impacts of diabetes over time course after acute myocardial infarction.糖尿病在急性心肌梗死后时间进程中的预后影响差异。
J Korean Med Sci. 2013 Dec;28(12):1749-55. doi: 10.3346/jkms.2013.28.12.1749. Epub 2013 Nov 26.
2
Association between pulse pressure at discharge and clinical outcomes in patients with acute myocardial infarction: From the KAMIR-Korean-NIH registry.出院时脉压与急性心肌梗死患者临床结局的关系:来自 KAMIR-Korean-NIH 注册研究。
J Clin Hypertens (Greenwich). 2019 Jun;21(6):774-785. doi: 10.1111/jch.13534. Epub 2019 Apr 23.
3
Effects of Statin Therapy on Clinical Outcomes of Survivors of Acute Myocardial Infarction with Severe Systolic Heart Failure.他汀类药物治疗对重度收缩性心力衰竭急性心肌梗死幸存者临床结局的影响。
PLoS One. 2015 Dec 11;10(12):e0144602. doi: 10.1371/journal.pone.0144602. eCollection 2015.
4
Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.急性心肌梗死患者新检测到的血糖异常的持续预后意义:急性心肌梗死患者糖耐量队列的长期随访
Diab Vasc Dis Res. 2015 Jan;12(1):23-32. doi: 10.1177/1479164114551746. Epub 2014 Oct 13.
5
GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry.急性心肌梗死后的肾小球滤过率与心血管结局:来自韩国急性心肌梗死注册研究的结果。
Am J Kidney Dis. 2012 Jun;59(6):795-802. doi: 10.1053/j.ajkd.2012.01.016. Epub 2012 Mar 23.
6
Comparison of 2-year clinical outcomes between diabetic versus nondiabetic patients with acute myocardial infarction after 1-month stabilization: Analysis of the prospective registry of DIAMOND (DIabetic acute myocardial infarctiON Disease) in Korea: an observational registry study.糖尿病与非糖尿病急性心肌梗死患者1个月病情稳定后2年临床结局的比较:韩国DIAMOND(糖尿病急性心肌梗死疾病)前瞻性注册研究分析:一项观察性注册研究
Medicine (Baltimore). 2016 Jun;95(25):e3882. doi: 10.1097/MD.0000000000003882.
7
Does Diabetes Mellitus Increase the Short- and Long-Term Mortality in Patients With Critical Acute Myocardial Infarction? Results From American MIMIC-III and Chinese CIN Cohorts.糖尿病是否会增加重症急性心肌梗死患者的短期和长期死亡率?来自美国 MIMIC-III 和中国 CIN 队列的结果。
Front Endocrinol (Lausanne). 2021 Dec 14;12:797049. doi: 10.3389/fendo.2021.797049. eCollection 2021.
8
Long-term prognosis of patients with acute myocardial infarction in the era of acute revascularization (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] registry).急性再血管化时代急性心肌梗死患者的长期预后(来自日本心脏病学会急性心肌梗死注册研究[HIJAMI])。
Int J Cardiol. 2012 Sep 6;159(3):205-10. doi: 10.1016/j.ijcard.2011.02.072. Epub 2011 Mar 12.
9
Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry).急性心肌梗死后30天存活者6个月主要不良心脏事件的预测因素(来自韩国急性心肌梗死登记处)
Am J Cardiol. 2009 Jul 15;104(2):182-9. doi: 10.1016/j.amjcard.2009.03.010.
10
Which is the worst risk factor for the long-term clinical outcome? Comparison of long-term clinical outcomes between antecedent hypertension and diabetes mellitus in South Korean acute myocardial infarction patients after stent implantation.哪种风险因素对长期临床结局的影响最大?支架植入术后韩国急性心肌梗死患者中既往高血压与糖尿病对长期临床结局的比较。
J Diabetes. 2020 Feb;12(2):119-133. doi: 10.1111/1753-0407.12979. Epub 2019 Sep 9.

引用本文的文献

1
Risk factors for repeat percutaneous coronary intervention in young patients (≤45 years of age) with acute coronary syndrome.年轻急性冠状动脉综合征患者(≤45岁)重复经皮冠状动脉介入治疗的危险因素。
PeerJ. 2019 Apr 26;7:e6804. doi: 10.7717/peerj.6804. eCollection 2019.
2
High quality process of care increases one-year survival after acute myocardial infarction (AMI): A cohort study in Italy.高质量的医疗护理可提高急性心肌梗死(AMI)患者一年后的生存率:意大利的一项队列研究。
PLoS One. 2019 Feb 20;14(2):e0212398. doi: 10.1371/journal.pone.0212398. eCollection 2019.
3
Clinical and Economic Analysis of Lipid Goal Attainments in Chinese Patients with Acute Coronary Syndrome Who Received Post-Percutaneous Coronary Intervention.

本文引用的文献

1
New horizons of acute myocardial infarction: from the Korea Acute Myocardial Infarction Registry.急性心肌梗死的新视野:来自韩国急性心肌梗死注册研究。
J Korean Med Sci. 2013 Feb;28(2):173-80. doi: 10.3346/jkms.2013.28.2.173. Epub 2013 Jan 29.
2
Sex differences in management and mortality of patients with ST-elevation myocardial infarction (from the Korean Acute Myocardial Infarction National Registry).ST 段抬高型心肌梗死患者管理和死亡率的性别差异(来自韩国急性心肌梗死国家注册研究)。
Am J Cardiol. 2012 Mar 15;109(6):787-93. doi: 10.1016/j.amjcard.2011.11.006. Epub 2011 Dec 22.
3
Impact of diabetes mellitus on long-term follow-up of percutaneous coronary intervention based on clinical presentation of coronary artery disease.
中国经皮冠状动脉介入治疗后急性冠状动脉综合征患者血脂目标达成的临床和经济分析。
J Atheroscler Thromb. 2018 Dec 1;25(12):1255-1273. doi: 10.5551/jat.44818. Epub 2018 Jun 29.
4
The scientific achievements of the decades in Korean Acute Myocardial Infarction Registry.韩国急性心肌梗死注册研究数十年的科学成就。
Korean J Intern Med. 2014 Nov;29(6):703-12. doi: 10.3904/kjim.2014.29.6.703. Epub 2014 Oct 31.
基于冠状动脉疾病的临床表现,糖尿病对经皮冠状动脉介入治疗的长期随访的影响。
J Cardiovasc Med (Hagerstown). 2011 Jun;12(6):405-10. doi: 10.2459/JCM.0b013e3283448695.
4
Comparison of clinical outcomes following acute myocardial infarctions in hypertensive patients with or without diabetes.比较有或无糖尿病的高血压患者急性心肌梗死的临床结局。
Korean Circ J. 2009 Jun;39(6):243-50. doi: 10.4070/kcj.2009.39.6.243. Epub 2009 Jun 30.
5
Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction.ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后30天和1年死亡率的预测因素。
Coron Artery Dis. 2009 Sep;20(6):415-21. doi: 10.1097/MCA.0b013e32832e5c4c.
6
Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry).急性心肌梗死后30天存活者6个月主要不良心脏事件的预测因素(来自韩国急性心肌梗死登记处)
Am J Cardiol. 2009 Jul 15;104(2):182-9. doi: 10.1016/j.amjcard.2009.03.010.
7
Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus.糖尿病患者与非糖尿病患者急性冠状动脉综合征的治疗及预后比较。
Am J Cardiol. 2009 Mar 15;103(6):772-8. doi: 10.1016/j.amjcard.2008.11.034. Epub 2009 Jan 24.
8
Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.预测非ST段抬高型急性冠状动脉综合征临床事件的发生风险:全球急性冠状动脉事件注册研究
Heart. 2009 Jun;95(11):888-94. doi: 10.1136/hrt.2008.153387. Epub 2009 Feb 25.
9
Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.普拉格雷对接受经皮冠状动脉介入治疗的急性冠脉综合征患者的早期和晚期获益:TRITON-TIMI 38(通过普拉格雷优化血小板抑制评估治疗转归改善的试验-心肌梗死溶栓38)分析
J Am Coll Cardiol. 2008 May 27;51(21):2028-33. doi: 10.1016/j.jacc.2008.04.002.
10
Short- and long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus.急性心肌梗死后的短期和长期死亡率:糖尿病患者与非糖尿病患者的比较。
Eur J Epidemiol. 2007;22(12):883-8. doi: 10.1007/s10654-007-9191-5. Epub 2007 Oct 10.